Seroquel
Seroquel Price range: $ 40,00 through $ 600,00
Back to products
Shallaki
Shallaki Price range: $ 53,00 through $ 203,00

Serpina

Price range: $ 41,00 through $ 246,00

Serpina is a natural herbal supplement formulated to support healthy blood pressure levels and cardiovascular wellness. Derived from the Rauwolfia serpentina plant, this time-tested remedy helps manage mild to moderate hypertension effectively. Its unique properties work by reducing the heart rate and dilating blood vessels to promote smoother blood flow throughout the body. Additionally, Serpina aids in relieving symptoms of anxiety and nervous tension, fostering a sense of calm and mental relaxation. This standardized extract provides a dependable, plant-based solution for maintaining overall circulatory health and emotional balance.

Active substance: Sarpagandha
SKU: Serpina Categories: , ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Serpina is a botanical formulation derived primarily from Rauwolfia serpentina, a plant recognized in traditional pharmacopeias for its yield of active indole alkaloids. The primary bioactive constituent, reserpine, acts upon both central and peripheral autonomic nervous system structures to modulate cardiovascular tone and neural excitability.

In the United States, products containing plant-derived active alkaloids are subject to federal and state regulation regarding quality, labeling, and therapeutic claims, and this product is dispensed in accordance with applicable federal and state regulations. Patients utilizing this preparation should do so under the oversight of a qualified healthcare provider to ensure appropriate clinical monitoring.

Attribute Details
Drug name Serpina
Active ingredient (INN) Rauwolfia serpentina root extract (standardized alkaloids including reserpine)
Therapeutic class Antihypertensive / Central monoamine depleting agent (botanical derivative)
Dosage form Oral tablet
Route of administration Oral
Prescription status Dispensed in accordance with applicable federal and state regulations

Pharmacological Characteristics and Clinical Use

How the drug works

The mechanism of action relies on the depletion of monoamine neurotransmitters–specifically norepinephrine, dopamine, and serotonin (5-HT)–from central and peripheral postganglionic adrenergic neurons. The active alkaloid components, notably reserpine, bind irreversibly to vesicular monoamine transporters (VMAT1 and VMAT2). This binding prevents the reuptake and storage of monoamines within presynaptic storage vesicles, exposing the neurotransmitters to enzymatic degradation by cytoplasmic monoamine oxidase. As neuronal stores become depleted, sympathetic nerve impulse transmission is blunted. The resulting reduction in peripheral vascular resistance produces a gradual decrease in blood pressure, accompanied by mild central nervous system sedation and slowing of the heart rate.

What it’s used for

Historically and within traditional medical systems, preparations derived from Rauwolfia serpentina have been utilized for the supportive management of mild to moderate essential hypertension. Additionally, the central neuro-depressant properties of its constituent alkaloids have supported its application in addressing mild states of vascular tension and stress-associated neuropsychiatric agitation. In modern healthcare settings within the United States, treatment of diagnosed hypertension requires clinical oversight; use of botanical monoamine depletors for blood pressure reduction is considered an adjunct or off-label application relative to standard antihypertensive pharmacotherapy. It is not indicated for the acute management of severe or malignant hypertension.

Dosing schedule

The dosing schedule is determined individually by a managing physician based on baseline blood pressure, physiological response, and tolerability. Standard clinical administration typically involves oral intake of one tablet once or twice daily, taken following meals to minimize direct gastrointestinal irritation. Because the pharmacological depletion of neurotransmitter vesicles requires time to achieve steady-state physiological effects, dosage modifications must be made cautiously and at extended intervals. Patients must not self-adjust doses or double up on tablets following a missed schedule.

How it’s absorbed and eliminated

Following oral administration, active alkaloids derived from Rauwolfia serpentina are absorbed through the gastrointestinal tract, though systemic bioavailability varies based on individual digestive kinetics. Reserpine exhibits extensive tissue distribution and readily crosses both the blood-brain barrier and the placental barrier. Hepatic metabolism occurs predominantly via oxidative and hydrolytic pathways. Elimination is prolonged due to tight tissue binding and the irreversible nature of transporter inhibition; while the plasma elimination half-life of reserpine ranges from approximately 4.5 to 33 hours, biological activity persists for up to 1 to 2 weeks post-discontinuation until new storage vesicles are endogenously synthesized.

Storage and expiration

Store the medication at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with excursions permitted between 59°F and 86°F (15°C to 30°C). Protect the container from excessive heat, high humidity, and direct sunlight. Keep the bottle tightly closed in a dry location, avoiding storage in bathroom cabinets. Always check the expiration date printed on the packaging prior to use, and safely dispose of out-of-date tablets in accordance with local pharmacy disposal protocols.

Safety Profile and Precautions

Compatibility with other medicines

Concomitant administration with monoamine oxidase inhibitors (MAOIs) is strictly contraindicated or requires a minimum washout period, as simultaneous use can provoke severe hyperpyrexia and acute hypertensive crises. Combining this agent with central nervous system depressants, such as benzodiazepines, barbiturates, alcohol, or opioids, results in additive hypnotic and respiratory depressant effects. Co-administration with digitalis glycosides (digoxin) increases the risk of sinus bradycardia and cardiac arrhythmias. Furthermore, concurrent use with prescription antihypertensive agents (e.g., ACE inhibitors, beta-blockers, or diuretics) may induce profound orthostatic hypotension, requiring careful clinical dosage adjustments.

Adverse reactions

Adverse reactions stem primarily from unchecked parasympathetic tone and central monoamine depletion. Common side effects include nasal mucosal congestion, dry mouth, increased gastric acid secretion, hypermotility leading to abdominal cramps or diarrhea, and peripheral edema. Central nervous system reactions frequently manifest as drowsiness, lethargy, dizziness, vivid dreams, and extrapyramidal symptoms. Serious adverse reactions include severe drug-induced depressive states, marked sinus bradycardia, gastrointestinal ulceration or hemorrhage, and significant orthostatic hypotension. Development of despondency or altered mood requires immediate clinical evaluation.

Important precautions

This formulation carries significant warnings regarding psychiatric and gastrointestinal safety. Patients with an active diagnosis or history of major depressive disorder should not use this medication, as depletion of central serotonin and catecholamines can precipitate deep clinical depression and suicidal ideation. Active peptic ulcer disease, ulcerative colitis, and gallstones represent absolute contraindications due to stimulated gastric acid production and increased intestinal motility. Caution is mandatory in individuals with pre-existing sinus bradycardia, cardiac conduction defects, or renal impairment.

Special populations

Use during pregnancy is not recommended; reserpine crosses the placenta and can induce fetal harm, neonatal cyanosis, hypothermia, excessive respiratory secretions, and bradycardia. Lactating mothers must avoid this medication, as active alkaloids pass into breast milk and pose risks of sedation and respiratory compromise to the nursing infant. Geriatric patients exhibit heightened sensitivity to central nervous system depression and orthostatic hypotension, necessitating lower initial doses and frequent monitoring. Safety and efficacy in pediatric populations have not been clinically established.

What to avoid while taking it

Alcohol consumption must be completely avoided during therapy. Ethanol enhances both the central depressant properties and the vasodilatory actions of the active alkaloids, significantly increasing the likelihood of severe sedation, motor impairment, and orthostatic dizziness. While food does not markedly alter systemic bioavailability, taking tablets alongside meals helps mitigate localized gastrointestinal discomfort and hyperacidity.

Red flags

Immediate emergency medical attention must be sought if signs of severe adverse toxicity occur. Critical red flags include:

  • Sudden onset of severe despondency, severe mood changes, or suicidal thoughts
  • Signs of gastrointestinal bleeding, such as black tarry stools or vomiting blood
  • Severe bradycardia (heart rate dropping significantly below 50 beats per minute)
  • Difficulty breathing, persistent wheezing, or chest tightness
  • Profound lightheadedness, confusion, or syncope (fainting)
  • Signs of acute hypersensitivity, including swelling of the face, lips, tongue, or throat

How long does it take to observe a reduction in blood pressure after starting therapy?

The cardiovascular response to Rauwolfia serpentina alkaloids develops gradually rather than immediately. Initial physiological actions may become apparent within several days, but maximum therapeutic efficacy typically requires two to three weeks of continuous, consistent administration. This delayed onset is due to the time required for cumulative depletion of vesicular catecholamine stores within sympathetic nerve endings.

What should be done if a scheduled dose is missed?

If a dose is missed, it should be taken as soon as remembered, provided it is not close to the time for the next scheduled dose. If the next dose is due shortly, skip the missed dose and resume the regular administration schedule. Patients must never double the dose or take additional tablets to compensate for a missed administration, as this elevates the risk of severe hypotension and central depression.

Is it safe to drive or operate machinery while taking this medication?

Caution must be exercised when operating motor vehicles or machinery. Because active alkaloids can induce central nervous system sedation, somnolence, slowed reaction times, and orthostatic dizziness–particularly during the initial weeks of treatment–patients should confirm how the product affects their alertness before engaging in potentially hazardous activities.

Can this product be stopped abruptly after prolonged use?

Abrupt cessation of therapy should be avoided under normal clinical circumstances. Gradual discontinuation under medical supervision is recommended to prevent potential rebound autonomic instability or blood pressure fluctuations. Because tissue-bound alkaloids persist long after administration ceases, physiological effects dissipate slowly over one to two weeks following withdrawal.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA guidelines, this overview does not constitute individual medical advice or diagnostic evaluation.

Additional information
Dosage

60caps

Package

1 bottles

,

2 bottles

,

3 bottles

,

4 bottles

,

5 bottles

,

6 bottles

,

7 bottles

,

8 bottles

,

9 bottles

,

10 bottles

Ενεργός Ουσία